[摘要] 目的 探讨罗盖全治疗透析患者甲状旁腺功能亢进的治疗效果。方法 方便选取该院2014年2月—2017年2月收治的血液透析治疗的SHPT患者44例为观察对象，随机将患者分为2组各22例，冲击组给予透析后当晚空腹顿服罗盖全冲击治疗，常规组给予罗盖全常规剂量治疗，观察两组症状改善及各指标变化。结果 冲击组骨痛缓解86.4%、四肢无力缓解45.5%、皮肤瘙痒缓解72.7%，明显优于常规组(P<0.05)；两组治疗后比较，冲击组血钙(2.13±0.16)mmol/L、钙磷乘积(4.04±0.67)mg2/L2、iPTH(247.25±98.24)pg/mL等指标与常规组比较有差异有统计学意义(P<0.05)。结论 罗盖全冲击治疗透析患者SHPT可显著降低iPTH，缓解患者症状，值得应用。

    [关键词] 罗盖全；透析；甲状旁腺功能亢进

    [中图分类号] R582 [文献标识码] A [文章编号] 1674-0742(2017)11(a)-0126-03

    [Abstract] Objective To study the effect of rocaltrol in treatment of hyperparathyroidism dialysis patients. Methods 44 cases of SHPT dialysis patients in our hospital from February 2014 to February 2017 were convenient selected and randomly divided into two groups with 22 cases in each ......